Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

Clinical trial NCT04726553 · UNKNOWN

Trial details

NCT number: NCT04726553
Sponsor: Oklahoma Medical Research Foundation
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)

Start date: 2021-01-20
Primary completion: 2023-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.